Most general and medical dermatologists treat patients with autoimmune skin disease. Most of these dermatologists possess the knowledge that treatment of such patients with chronic glucocorticoids can lead to bone resorption and osteoporosis.1 Yet, one gap, identified in the article by Wohl et al, is that the percentage of dermatologists who comply with the current guidelines for screening, prevention, and management of osteoporosis remains suboptimal. According to the study, over half of at-risk patients had undergone no DEXA scan in more than 5 years.
J. Stratman E. Underutilization of Prophylaxis for OsteoporosisComment on “Pemphigus and Osteoporosis”. Arch Dermatol. 2010;146(10):1131. doi:10.1001/archdermatol.2010.250